文献速递主动脉疾病颈动脉与弓上血管

复杂迷走锁骨下动脉杂交TEVAR修复的安全性与疗效

Safety and efficacy of a hybrid approach for repair of complicated aberrant subclavian arteries.
PubMed 文献 · J Vasc Surg · 2020-07-19

单中心回顾18例因迷走锁骨下动脉(ASA)并发症行杂交TEVAR的患者,围术期无死亡及脊髓缺血,技术成功率83%,随访中44%出现内漏,1年免于再干预率75%±10%,1年与3年生存率分别为93%±6%和84%±10%。作者认为该术式安全且有一定疗效,但内漏问题影响耐久性,需强调术后监测。

要点

  • 杂交TEVAR治疗复杂ASA围术期风险低,无死亡和脊髓缺血事件。
  • 随访内漏率达44%,需重视术后监测与再干预风险。
  • 主动脉重塑尚可,78%患者瘤径缩小或稳定。

核心结论

  • 杂交开放头臂动脉血运重建联合TEVAR治疗ASA并发症安全且较为有效,但内漏率引发对耐久性的担忧。
  • 若采用该技术,术前应强调强制监测的必要性和较高的再干预率。

研究设计与样本

  • 回顾性单中心研究,纳入2002至2018年因ASA并发症接受杂交TEVAR的全部患者。
  • 共18例,占1240例TEVAR的1.4%;男性67%,年龄59±13岁。

主要发现

  • 围术期无死亡及脊髓缺血事件,主要并发症发生率22%(n=4)。
  • 技术成功率为83%,随访(中位4个月)中44%(n=8)出现内漏。
  • 中位KD直径缩小7 mm,78%(n=14)瘤径缩小或稳定。
  • 1年免于再干预率为75%±10%,1年与3年生存率分别为93%±6%和84%±10%。

关键数值与推荐

  • 技术成功定义为术中及术后30天内无I型或III型内漏。
  • 术前KD中位直径为60 mm(IQR 37-108 mm)。
  • 手术指征包括瘤径(61%)、吞咽困难(17%)、破裂(11%)、快速扩张(6%)及TEVAR后内漏(6%)。

临床怎么用

  • 可用于合并吞咽困难或Kommerell憩室瘤样变的复杂ASA患者。
  • 术前需告知患者术后需长期影像监测及较高再干预风险。

局限性

  • 单中心回顾性设计,样本量仅18例。
  • 随访时间短(中位4个月),需更大样本和更长随访验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Aberrant subclavian artery (ASA), a well-described aortic arch anomaly, is frequently associated with dysphagia and development of Kommerell diverticulum (KD) with aneurysmal degeneration. Historically, open repair has been performed, which can be associated with significant morbidity. More recently, hybrid approaches using different arch vessel revascularization techniques in combination with thoracic endovascular aortic repair (hybrid TEVAR) have been described, but there is a paucity of literature describing outcomes. The objective of this analysis was to describe our experience with management of complicated ASAs using hybrid TEVAR, further adding to the literature describing approaches to and outcomes of hybrid ASA repair. METHODS: A retrospective, single-institution review was performed of all patients treated for ASA complications using hybrid TEVAR (2002-2018). The primary end point was technical success, defined as absence of type I or type III endoleak intraoperatively and within 30 days postoperatively. Secondary end points included complications, reintervention, and survival. Centerline measurement of KD diameters (maximum diameter = opposing aortic outer wall to diverticulum apex) was employed. Kaplan-Meier methodology was used to estimate secondary end points. RESULTS: Eighteen patients (1.4% of 1240 total TEVAR procedures; male, 67%; age, 59 ± 13 years) were identified (left-sided arch and right ASA, 94% [n = 17]; right-sided arch and left ASA, n = 1 [6%]; retroesophageal location and associated KD, 100%); median preoperative KD diameter was 60 mm (interquartile range [IQR], 37-108 mm). Operative indications included diverticulum diameter (61%), dysphagia (17%), rupture (11%), rapid expansion (6%), and endoleak after TEVAR (6%). All procedures used some combination of supraclavicular revascularization and TEVAR (staged, 50% [n = 9]), whereas partial open arch reconstruction was used in 17% (n = 3). There were no perioperative deaths or spinal cord ischemic events. Major complications occurred in 22% (n = 4): nondisabling stroke, one; arm ischemia, one; upper extremity neuropathy, one; and iatrogenic descending thoracic aortic dissection, one. Technical success was 83%, but 44% (n = 8) had an endoleak (type I, n = 3; type II, n = 5 [intercostal, n = 2; aneurysmal subclavian artery origin, n = 3]) during follow-up (median, 4 months; IQR, 1-15 months). Two endoleaks resolved spontaneously, three were treated, and three were observed (1-year freedom from reintervention, 75% ± 10%). Median KD diameter decreased by 7 mm (IQR, 1-12 mm), and 78% (n = 14) experienced diameter reduction or stability in follow-up. The 1- and 3-year survival was 93% ± 6% and 84% ± 10%, respectively. CONCLUSIONS: Hybrid open brachiocephalic artery revascularization with TEVAR appears to be safe and reasonably effective in management of ASA complications as evidenced by a low perioperative complication risk and reasonable positive aortic remodeling. However, endoleak rates raise significant concerns about durability. Therefore, if this technique is employed, the mandatory need for surveillance and high rate of reintervention should be emphasized preoperatively. This analysis represents a relatively large series of a hybrid TEVAR technique to treat ASA complications, but greater patient numbers and longer follow-up are needed to further establish the role of this procedure.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Gray SE, Scali ST, Feezor RJ, et al. Safety and efficacy of a hybrid approach for repair of complicated aberrant subclavian arteries. J Vasc Surg. 2020. PMID: 32665182. doi:10.1016/j.jvs.2020.01.075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。